| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| mapatumumab | trail receptor 1 | NA | Clinical trial target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
79.56 | phase 2 | agonist |
| mapatumumab | trail receptor 1 | NA | Clinical trial target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
79.56 | phase 2 | antibody |
| mapatumumab | trail receptor 1 | NA | Clinical trial target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
79.56 | phase 2 | unknown |
| click here to return to the previous page | ||||||||